procedures and provides direct access to homochiral products
from commercially available starting materials. It will be
interesting to investigate further spermidine analogues in the
AsbA-mediated catalytic enantioselective desymmetrisation of
citric acid to see whether an expanded range of compounds
can be produced. It will also be interesting to examine whether
other NIS synthetases possess similar stereoselectivity.
This work was supported by a grant from the BBSRC
(grant ref. BB/FO13760/1).
Notes and references
1 (a) M. Willis, J. Chem. Soc., Perkin Trans. 1, 1999, 1765–1784;
(b) T. Rovis, in New Frontiers in Asymmetric Catalysis, ed.
M. Koichi and M. Lautens, John Wiley & Sons, Hoboken, USA,
2007, ch. 9, pp. 275–311.
2 E. Garcia-Urdiales, I. Alfonso and V. Gotor, Chem. Rev., 2005,
105, 313–354.
3 M. D. Mihovilovic, Curr. Org. Chem., 2006, 10, 1265–1287.
4 A. T. Koppisch, S. Dhungana, K. K. Hill, H. Boukhalfa,
H. S. Heine, L. A. Colip, R. B. Romero, Y. Shou,
L. O. Ticknor, B. L. Marrone, L. E. Hersman, S. Iyer and
C. E. Ruggiero, BioMetals, 2008, 21, 581–589.
5 S. Cendrowski, W. MacArthur and P. Hanna, Mol. Microbiol.,
2004, 51, 407–417.
6 R. J. Abergel, M. K. Wilson, J. E. L. Arceneaux, T. M. Hoette,
R. K. Strong, B. R. Byers and K. N. Raymond, Proc. Natl. Acad.
Sci. U. S. A., 2006, 103, 18499–18503.
7 (a) J. Y. Lee, B. K. Janes, K. D. Passalacqua, B. F. Pfleger,
N. H. Bergman, H. Liu, K. Hakansson, V. S. Ravindranadh,
C. A. Courtney, S. Cendrowski, P. C. Hanna and
D. H. Sherman, J. Bacteriol., 2007, 189, 1698–1710;
(b) B. F. Pfleger, J. Y. Lee, R. V. Somu, C. C. Aldrich,
P. C. Hanna and D. H. Sherman, Biochemistry, 2007, 46,
4147–4157; (c) D. Oves-Costales, N. Kadi, M. J. Fogg, L. Song,
K. S. Wilson and G. L. Challis, J. Am. Chem. Soc., 2007, 129,
8416–8417; (d) D. Oves-Costales, N. Kadi, M. J. Fogg, L. Song,
K. S. Wilson and G. L. Challis, Chem. Commun., 2008, 4034–4036;
(e) A. T. Koppisch, K. Hotta, D. T. Fox, C. E. Ruggiero,
C. Y. Kim, T. Sanchez, S. Iyer, C. C. Browder, P. J. Unkefer
and C. J. Unfeker, J. Org. Chem., 2008, 73, 5759–5765;
(f) B. F. Pfleger, Y. Kim, T. D. Nusca, N. Maltseva, J. Y. Lee,
C. M. Rath, J. B. Scaglione, B. K. Janes, E. C. Anderson,
N. H. Bergman, P. C. Hanna, A. Joachimiak and
D. H. Sherman, Proc. Natl. Acad. Sci. U. S. A., 2008, 105,
17133–17138; (g) D. T. Fox, K. Hotta, C. Y. Kim and
A. T. Koppisch, Biochemistry, 2008, 47, 12251–12253.
Fig. 3 Structures of citric acid and tricarballylic acid derivatives
produced using analogues of spermidine and citric acid in AsbA-
catalysed reactions. Diagnostic fragment ions observed in MS/MS
spectra of compounds 5–8 and 12 and calculated (C) and found (F)
parent ion m/z values are indicated.
purified by reverse-phase HPLC from a scaled-up incubation
and HRMS and MS/MS analyses were consistent with struc-
ture 12 (Fig. 3 and ESIw). From these experiments we conclude
that AsbA is significantly more selective towards citric acid
than spermidine as a substrate. It would be interesting to
investigate whether AsbA shows the same high degree of
enantioselectivity in the desymmetrisation of tricarballylic acid
as in the desymmetrisation of citric acid. The lack of a
convenient method for the preparation of homochiral labelled
tricarballylic acid prevented us from pursuing this question in
the present study.
8 D. P. Bloxham, D. C. Parmelee, S. Kumar, R. D. Wade,
L. H. Ericsson, H. Neurath, K. A. Walsh and K. Titani, Proc.
Natl. Acad. Sci. U. S. A., 1981, 78, 5381–5385.
9 N1-(3,4-dihydroxybenzoyl)-spermidine is a potential intermediate in
petrobactin biosynthesis. We previously reported that we could
detect no activity with this spermidine analogue as a substrate for
AsbA.7c Here we employed lower concentrations of this compound
than in our previous experiments. High concentrations of the
compound appear to inhibit the enzyme, as suggested by the
decreased amounts of 11 produced with higher concentrations of
N1-(3,4-dihydroxybenzoyl)-spermidine. We employed our pre-
viously reported7d AMP release assay to measure the relative rates
of product formation using concentrations of ATP and citric acid
presumed to be well above the Km, with different concentrations of
N1-(3,4-dihydroxybenzoyl)-spermidine. In all cases the measured
rates were comparable to the background rate of AMP forma-
tion resultingfrom ATP hydrolysis and much lower than the
In conclusion, we have shown that the petrobactin bio-
synthetic enzyme AsbA catalyses the highly enantioselective
desymmetrisation of citric acid via the condensation of one of
its prochiral carboxyl groups with spermidine. The enzyme can
also catalyse the condensation of several di- and triamine
analogues of spermidine with citric acid and the condensation
of the citric acid analogue tricarballylic acid with spermidine.
These data indicate that AsbA could be developed into a
useful and novel biocatalyst for the preparation of homochiral
citric acid derivatives. To the best of our knowledge there are
only two other methods for the preparation of homochiral
citric acid derivatives. One involves the regio- and enantio-
selective esterase-catalysed hydrolysis of citrate triesters.10 The
other involves resolution by repeated fractional crystallisation
of the brucine salts of 1,2-diesters of citric acid.11 The bio-
transformation reported here is highly complimentary to these
rates observed using spermidine as
a substrate. These data
provide further support for our previous conclusion7c,d that
N1-(3,4-dihydroxybenzoyl)-spermidine is not a significant inter-
mediate in petrobactin biosynthesis.
10 R. Chenevert, B. Ngatcha, T. Beatrice, Y. Rose, S. Yannick and
D. Goupil, Tetrahedron: Asymmetry, 1998, 9, 4325–4329.
11 R. J. Bergeron, M. Xin, R. E. Smith, M. Wollenweber,
J. S. McManis, C. Ludit and K. A. Abboud, Tetrahedron, 1997,
53, 427–434.
ꢀc
This journal is The Royal Society of Chemistry 2009
Chem. Commun., 2009, 1389–1391 | 1391